Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera...
Brief Summary
Official Title: “Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study”
This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera.
- Study Type: Observational
- Study Design: Observational Model: Ecologic or Community, Time Perspective: Prospective
- Study Primary Completion Date: September 2008
Detailed Clinical Trial Description
Approximately 1600 young women will be enrolled in a 12 month, observation study of their contraceptive use. They will complete surveys at baseline, 3, 6 and 12 months. They will also undergo pregnancy testing at baseline, 6 and 12 month visits. The study is examining such things are the relationship between partnerships, parental and peer influences, and contraceptive choice; Factors associated with long term continuation of contraceptive methods; Attributes of new hormonal contraceptive associated with user satisfaction and long-term continuation; And the extent to which high-risk women who use these methods are also condom users and determine the characteristics of these users.
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- 15-24 years old, English or spanish speaking, Starting ring, pill, patch, or Depo for first time, Sexually active, Single, Not pregnant, Living in Bay Area for next 12 months
Exclusion Criteria:
- Past user of method, Married, Pregnant, Moving out of area, Not sexually active
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: 15 Years
Maximum Age for this Clinical Trial: 24 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: University of California, San Francisco Other
Overall Clinical Trial Officials and Contacts
Tina R Raine, MD, MPH Principal Investigator University of California, San Francisco
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00361400
Study ID Number: R01-HD045480-03
ClinicalTrials.gov Identifier: NCT00361400
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00361400
